Navigation Links
Genzyme in Medical News

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

NEW YORK, April 13 /PRNewswire-FirstCall/ -- A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.'s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he j...

FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility

Has No Foreseeable Impact on Aldurazyme Sales NOVATO, Calif., March 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility duri...

Millennium Research Group Analyst Available to Comment on FDA's Premarket Approval Recommendation of Genzyme Biosurgery's Synvisc Single-Injection Product for the Knee

WALTHAM, Mass., Dec. 12 /PRNewswire/ -- Millennium Research Group (MRG) analyst Deanna Vankessel, author of the recently published G lobal Markets for Hyaluronic Acid Viscosupplementation 2008 report, is available to offer extensive expertise on the recent FDA premarket approval recommendati...

Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease

CAMBRIDGE, Mass., May 7 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) reported today that a preliminary analysis of data from an ongoing open-label Phase 2 clinical trial of its investigational oral therapy Genz-112638 showed that the compound produced a meaningful impact on key cli...

Bioenvision Shareholders Approve Acquisition by Genzyme Corporation

CAMBRIDGE, Mass., and NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ ) and Bioenvision, Inc. (Nasdaq: BIVN ) announced this afternoon that Bioenvision stockholders have voted to approve the acquisition of the company by Genzyme at a reconvened special sharehold...

Delaware Court Approves Bioenvision, Genzyme Joint Petition

Special Meeting to be Reconvened on October 22 NEW YORK and CAMBRIDGE, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Bioenvision, Inc. (Nasdaq: BIVN ) and Genzyme Corporation (Nasdaq: GENZ ) announced today that the Court of Chancery of the State of Delaware granted a petition filed ...

Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company

Major Shareholder Will NOT Vote for Merger; Says 'Shareholders Have Already Spoken' by Rejecting Tender Offer at $5.60 per Share NEW YORK, Sept. 6 /PRNewswire-FirstCall/ -- Elliott Associates, L.P. (together with funds under common management), a major shareholder of Bioenvision (Nasdaq...

BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company

...d's top ten tenants are research institutions or A-rated public companies, including Beth Israel Deaconess Medical Center, Children's Hospital Boston, genzyme Corporation, Centocor, Inc. (a Johnson & Johnson subsidiary) and Schering Corporation. Each of BioMed's other top ten tenants publicly announced s...

BioMarin Announces Second Quarter 2009 Financial Results

... 22% increase Aldurazyme Net Sales by genzyme $39.2 1% increase Aldurazym...n increase of 1.0 percent compared to net sales by genzyme of $38.7 million for the second quarter of 2008. Net sales of Aldurazyme recorded by genzyme for the six months ended June 30, 2009 were $76.0 ...

Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R)( )(sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division o...
Genzyme in Medical Technology

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

Data Show Encouraging Results for a Potential New Front-Line Treatment Approach in AML CAMBRIDGE, Mass., June 2 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) reported preliminary data today from a fully-enrolled pivotal, phase 2 study examining the safety...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...e in revenue from the Company's collaboration with genzyme because the three and six months ended June 30, 20... Company received from its strategic alliance with genzyme in 2008 and the gain it recognized on the sale of ...s Highlights "During the last quarter, we and genzyme made great progress regarding mipomersen on two im...

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

...nt and commercialization of its programs, Fovea is working both independently and through collaborations with industrial partners like Dyax, Novartis, genzyme and CombinatoRx, as well as with academic teams, like the Inserm unit U968 (Vision Institute), the Rothschild Ophthalmological Foundation or the Joh...

BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome

...azyme(R) (laronidase) for MPS I is manufactured by BioMarin and marketed by genzyme Corporation. About MPS IVA Mucopolysaccharidosis IVA (MPS IV...I (MPS I), a product which was developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product ...

Pain Relief in Just One Visit with Genzyme's Synvisc-One

...opedic Biomaterials 2009 report, the US launch of genzyme Biosurgery's single-injection Synvisc-One will dri...ntly the only approved single-injection treatment, genzyme Biosurgery is positioned to benefit from this shif...thofix), DePuy, Exactech, Ferring Pharmaceuticals, genzyme Biosurgery, Integra LifeSciences, LifeNet Health, ...

PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy

...nt, evaluation, and marketing. PTC has an exclusive collaboration with genzyme Corporation for the development and commercialization of ataluren. PTC Therapeutics will market ataluren in the United States and Canada, while genzyme will commercialize the product in other regions of the world. The developm...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

...iled fludarabine therapy. Campath was developed by genzyme Corporation. Campath is marketed in the U.S. by Ba...preventing and treating diseases. About genzyme One of the world's leading biotechnology companies, genzyme is dedicated to making a major positive impact on ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

...led fludarabine therapy. Campath was developed by genzyme Corporation. Campath is marketed in the U.S. by B...preventing and treating diseases. About genzyme One of the world's leading biotechnology companies, genzyme is dedicated to making a major positive impact on ...

PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients

... The FDA has also granted PTC124 Subpart E designation for expedited development, evaluation, and marketing. PTC has an exclusive collaboration with genzyme Corporation to develop and commercialize PTC124 outside the United States and Canada. The development of PTC124 has also been supported by grants from...

BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with M...

More>>

Genzyme in Medical Products

Sepramesh Biosurgical Composite

Description:...s of a PPM mesh that has two distinct sides. One side of the mesh is coated with a layer of sodium hyaluronate and carboxymethylcellulose (similar to genzyme Biosurgery's Seprafilm® Adhesion Barrier). This coated side is bioresorbable, providing a temporary physical barrier that separates the underlying...
Company:Genzyme Biosurgery
Genzyme in Medical Dictionary

Genetics

...lar Genetics & Microbiology ... All News and Articles> ... How genzyme Can Help You Do More to Personalize TestingFor hematologic and solid tumor malignancies, genzyme provides an Antibody Library, and a FISH Probe Library. ... ... to the ...
Genzyme in Biological News

'Show me the money!' MDA greenlights grants

...ophic lateral sclerosis (ALS), or Lou Gehrig's disease, and spinal muscular atrophy. It also served as the basis for a lifesaving therapy developed by genzyme for a metabolic muscle disease called Pompe disease. At Columbia University, Schon has been awarded a three-year $400,000 grant to continue rese...

Muscle-targeted gene therapy reverses rare muscular dystrophy in mice

...h are characterized by progressive weakness and degeneration of the skeletal muscles which control movement. The Muscular Dystrophy Association and genzyme Corporation supported the research. Several forms of Pompe disease affect more than 5,000 people in the U.S. If symptoms appear during infancy, the...
Genzyme in Biological Technology

Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise

HOLMDEL, N.J., June 30 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its qualit...

BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture

BioMarin will Continue to Manufacture; Genzyme will Continue to Market and Sell Aldurazyme NOVATO, Calif. and CAMBRIDGE, Mass., Jan. 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) and Genzyme Corporation (Nasdaq: GENZ ) announced toda...

BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors

WOBURN, Mass., Oct. 25 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that it has appointed Jan van Heek, age 58, as Chairman of the Board of Directors. Mr. van Heek is employed as a...

Cytochroma settles lawsuit with Genzyme

Madison, Wis. - Cytochroma, Inc. , a company managed by former employees of Bone Care International, has announced the settling of a lawsuit filed in August 2006 by Genzyme Corp ., the company that acquired Bone Care in 2005. The lawsuit, in which Genzyme claimed that the former Bone Care em...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

...the substantia nigra. Once CERE-120 is delivered to the brain, it provides stable, long-lasting expression of neurturin in a highly targeted fashion. genzyme Corporation (Nasdaq: GENZ ) has licensed the ex-North American rights for the development and commercialization of CERE-120 from Ceregene, an agreem...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...ed in oncology and immunology. It wasn't all good news for biotechs. genzyme shares tumbled more than 6 percent in July following an announcement that t...cient action to correct equipment maintenance and process control problems. genzyme received an FDA warning letter in February citing manufacturing deficiencie...

PTC Therapeutics Receives $2.6 Million in Government Grants

...nt, evaluation, and marketing. PTC has an exclusive collaboration with genzyme Corporation for the development and commercialization of ataluren. PTC Therapeutics will market ataluren in the United States and Canada, while genzyme will commercialize the product in other regions of the world. The developm...

Kuvan Receives Priority Review Status From Health Canada

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of ...

BioMarin to Present at the Jefferies Healthcare Conference

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of ...

BioMarin to Present at the Goldman Sachs Healthcare Conference

...zed by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of ...
Genzyme in Biological Definition

Biotechnology

...rms The top 10 publicly-traded biotechnology companies, ranked by 2003 sales, are: Amgen Genentech Serono Biogen Idec Chiron genzyme MedImmune Gilead Sciences Cephalon Millennium Pharmaceuticals Biotechnology in fiction Star Trek The Breen use starship...
Genzyme in Biological Dictionary

Oligonucleotide

...lysis of oligonucleotide microarray design criteria to detect ... Supplying Every Link in the Peptide Chain – developed through the Mimotopes – genzyme Pharmaceuticals Global Alliance, providing seamless transition from supply of ... Oligonucleotide Oligo thermodynamic annealing temperature me...
Other Tags
(Date:12/26/2014)... Parker & Sons, Inc. a reliable ... cooling and plumbing contractor services throughout Arizona announces ... 2014 with regard to air-conditioning systems. Residential and ... for its incredibly hot summers. Working with an ... details of a wide variety of systems made ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... of the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ... Liebhard LLP reports. According to an Order issued in ... November 20th, the Court will convene an open conference ... Federal Building and United States Courthouse in West Palm ...
(Date:12/25/2014)... 26, 2014 Recently, Dylan Queen, a ... excitedly released its collection of discounted prom dresses, most ... a senior spokesman of the company, the promotion is ... promotion is to expand the UK market. , The ... different colors, lengths, and styles: A-line strapless, empire strapless ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 BambooFlooringChina.com sells ... high quality bamboo flooring. Today, the company announces ... in many styles and colors. , BambooFlooringChina.com is the ... CEO, the promotion is valid until Jan. 20, 2015. ... strips and woven with a natural thread. All the ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
(Date:11/18/2014)... 2014   News Highlights: ... develop The Partners Data Lake, an agile data ... Lake will allow researcher and clinicians to explore ... the lives of patients , The Partners ... across the Partners system, breaking down physical barriers ...
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock ... authentication solutions, and MorphoTrust USA (Safran), ... services, today announced a strategic partnership to offer ... motor vehicle administration (MVA), airport screening and financial ... identity-related solutions, MorphoTrust serves consumers through a nationwide ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
Other Contents